News Releases 2014

RSS

26 DEC 2014 Pharmaceuticals
New Drug Application Approval of TAKECAB® for the Treatment of Acid-related Diseases in Japan
23 DEC 2014 Pharmaceuticals
ARIAD and Otsuka Announced Co-development and
Commercialization Agreement for Iclusig® to Treat Leukemias in
Japan and Nine Other Asian Countries
19 DEC 2014 Nutraceuticals
Otsuka Pharmaceutical Saga Nutraceuticals Research Institute
Strengthens Focus on Sports Nutrition
Completion of New Artificial Environment Control Room
18 DEC 2014 Nutraceuticals
Otsuka Pharmaceutical Acquired US-based FoodState Inc.
Growing Supplement Business Through New Channels
11 DEC 2014 Pharmaceuticals
Otsuka And Lundbeck's Brexpiprazole Demonstrates Statistically Significant Effects In New Phase III Studies In Adult Patients With Schizophrenia Presented At The American College Of Neuropsychopharmacology Annual Meeting
10 DEC 2014 Pharmaceuticals
Otsuka And Lundbeck Present Phase III Data on Brexpiprazole As Adjunctive Therapy In Adult Patients With Major Depression At The American College Of Neuropsychopharmacology Annual Meeting
8 DEC 2014 Pharmaceuticals
U.S. FDA Approves The Labeling Update Of Abilify Maintena ® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia
2 DEC 2014 Corporate
Otsuka Pharmaceutical To Acquire Avanir Pharmaceuticals
21 NOV 2014 Pharmaceuticals
L-Cartin® FF Tablets For Carnitine Deficiencies To Be Introduced in Japan on December 5
Active Ingredient Carnitine in Free Form (FF*) to Address the Needs of Medical Field

Go to the Top

21 NOV 2014 Nutraceuticals
Nutrition & Sante Inaugurates New Factory
Expanding Production Base of the French Leader in Functional and Dietetic Foods
14 NOV 2014 Corporate
Otsuka Group Establishes New Company
in Order to Strengthen Presence in Vending Machine Market
12 NOV 2014 Corporate
Otsuka Pharmaceutical Tokushima Itano Factory Cosponsors 6th Asan Walking Festival in Itano Environmentally And Human-friendly Facility Maintains Close Ties to The Local Community
27 OCT 2014 Nutraceuticals
New product for Japanese women
Nature Made Fish Oil Pearl
Small Pearl-shaped Capsules Concentrated With Essential Nutritional Balance of Fish Oil
14 OCT 2014 Pharmaceuticals
Otsuka Pharmaceutical’s QuickNaviTM-Flu Influenza Diagnostic Kit to Provide Additional Diagnosis-Related Information
1 OCT 2014 Nutraceuticals
Calorie Mate Recipient of “G Mark” Good Design Long Life Design Award
24 SEP 2014 Pharmaceuticals
U.S. FDA Accepts Otsuka and Lundbeck’s Filing for Review of Brexpiprazole for the Treatment of Schizophrenia and as Adjunctive Therapy for the Treatment of Major Depression
16 SEP 2014 Nutraceuticals
Otsuka Pharmaceutical Launches “Next Generation Athlete Development Project” at the 17th Asian Games
Junior athletes experience world-class atmosphere at Asia’s largest competition
16 SEP 2014 Pharmaceuticals
A Marker to Monitor Treatment Effectiveness For Chronic Myeloid Leukemia(CML)
Approval in Japan for Otsuka’s Major BCR-ABL mRNA Measurement Kit
11 SEP 2014 Nutraceuticals
New Calorie Mate Block “Plain”
First simple, unadorned flavor marks a return to Calorie Mate origins after 32 years

Go to the Top

9 SEP 2014 Nutraceuticals
New SoyCarat Chili Pepper Flavor
Spicy version of healthy, low GI soy snack packs grown-up appeal
8 SEP 2014 Pharmaceuticals
A Change in the Treatment of Multidrug-Resistant Tuberculosis Begins
New Antituberculosis Drug Deltyba® in 50 mg Tablets, Available to Patients in Japan Starting September 26
28 AUG 2014 Nutraceuticals
Acquisition of Jasmine,
Leading Brazilian Health Food Company
6 AUG 2014 Nutraceuticals
UL・OS Announces New Skin Conditioner
Promoting the Habit of Skin Care for Middle-Aged Men
5 AUG 2014 Corporate
Otsuka Welfare Clinic for Refugees in Pakistan Awarded Foreign Minister’s
Commendation
4 AUG 2014 Pharmaceuticals
E Keppra® 500 mg Injectable For Monotherapy Treatment of Epilepsy Submitted For Regulatory Review in Japan
14 JUL 2014 Pharmaceuticals
Otsuka and Lundbeck Submit New Drug Application in The US for Brexpiprazole for The Treatment of Schizophrenia and as Adjunctive Therapy for The Treatment of Major Depressive Disorder
4 JUL 2014 Pharmaceuticals
After 40 Years, A New Drug For The Treatment Of Tuberculosis In Japan
Deltyba® (delamanid) Is The First Drug Approved In Japan Specifically For Pulmonary Multidrug-Resistant Tuberculosis (MDR-TB)
4 JUL 2014 Pharmaceuticals
E Keppra® Injectable Receives Marketing Authorization in Japan
Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged Four and Over
27 JUN 2014 Pharmaceuticals
Regulatory Approval Received in Japan For L-Cartin® FF Tablets 100 mg・250 mg Doses That Incorporate Carnitine in Free Form (FF)

Go to the Top

20 JUN 2014 Pharmaceuticals
Meptin®, a Fast-acting Bronchodilator to Treat Asthma and COPD, Will Become Available in Japan on July 2 in a New Form as Meptin® Swinghaler® 10μg 100Puffs
23 MAY 2014 Pharmaceuticals
Launch in Japan of Samsca 30 mg Tablet Formulation for Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD), an Orphan Disease
20 MAY 2014 Nutraceuticals
Otsuka Pharmaceutical Named the Major Official Sponsor of Inter-High School Athletic Championships for Two Consecutive Years
Special Website Features Fan-produced Support Movies and First Streaming Broadcast of All Competitions
15 MAY 2014 Nutraceuticals
Otsuka’s POCARI SWEAT Aims the Very First Moon Landing
Private Firms Take the Lead in the Start of “LUNAR DREAM CAPSULE PROJECT”
Delivering all children’s dreams 380,000KM to the moon
30 APR 2014 Pharmaceuticals
Otsuka Wins European Marketing Authorization for Deltyba™(delamanid)
9 APR 2014 Nutraceuticals
New SOYJOY Almond & Chocolate
Combines Crunchy Almonds, Subtly Sweet Chocolate and the Goodness of Soy
The Perfect Snack for Busy Business People
1 APR 2014 Nutraceuticals
POCARI SWEAT ION WATER
First Overseas Distribution Launched by King Car Otsuka in Taiwan
1 APR 2014 Pharmaceuticals
“QuickNavi Strep A” April 14 Market Launch in Japan
Test Kit for the Rapid Detection of Group A Beta-hemolytic Streptococcal Antigen
31 MAR 2014 Pharmaceuticals
Otsuka Acquires Rights to Hematological Cancer Treatment Dacogen® From Eisai (U.S.)
27 MAR 2014 Pharmaceuticals
Otsuka and Takeda Announce a Co-promotion Agreement in Japan of TAK-438 For the Treatment of Acid-related Diseases in the Gastrointestinal Therapeutic Area

Go to the Top

Go to the Top